Prostate Cancer - Results from #28060

UroToday Slide Library - mTOR: A new pathway to target in oncology June 1, 2011

UroToday Slide Library - PSA Nadir: A surrogate marker of long-term efficacy in HIFU therapy for localised prostate cancer June 1, 2011

UroToday Slide Library - The role of surgery in the high risk patient June 1, 2011

UroToday Slide Library - New strategies in the management of advanced neuroendocrine tumors June 1, 2011

UroToday Slide Library - The role of radiation therapy in the high risk patient June 1, 2011

UroToday Slide Library - Chemotherapy for high-risk disease at RRP June 1, 2011

UroToday Slide Library - Conclusions: Patupilone as a novel, alternative microtubule stabilizer June 1, 2011

UroToday Slide Library - The role of bisphosphonates in the high risk patient June 1, 2011

UroToday Slide Library - Treating PSA Recurrence June 1, 2011

UroToday Slide Library - New tools for the urologist in the management of patients with bone metastases June 1, 2011

UroToday Slide Library - High intensity focused ultrasound (HIFU) physical principles and future promise June 1, 2011

UroToday Slide Library - Salvage high intensity focused ultrasound for prostate cancer local relapse after radiation beam therapy June 1, 2011

UroToday Slide Library - Open questions on the role of HIFU as a low side effects option in the treatment of localized prostate cancer: "A medical oncologist point of view." June 1, 2011

UroToday Slide Library - Cryoblation as a primary prostate cancer treatment followed by penile rehabilitation June 1, 2011

UroToday Slide Library - Skeletal complications of GU malignancies— optimizing treatment with bisphosphonates June 1, 2011

UroToday Slide Library - Risk factors for the development of bone metastases in prostate cancer June 1, 2011

UroToday Slide Library - Bisphosphonates can prevent skeletal complications from prostate cancer June 1, 2011

Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum - Abstract May 31, 2011

Chemopreventive effects of tea in prostate cancer: Green tea versus black tea - Abstract May 31, 2011

Once-daily dasatinib: Expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer - Abstract May 31, 2011

Page 1404 of 1447